Inhaled corticosteroids and the risks of diabetes onset and progression

S Suissa, A Kezouh, P Ernst - The American journal of medicine, 2010 - Elsevier
BACKGROUND:: Systemic corticosteroids are known to increase diabetes risk, but the
effects of high-dose inhaled corticosteroids are unknown. We assessed whether the use and …

Significant variability in response to inhaled corticosteroids for persistent asthma

SJ Szefler, RJ Martin, TS King, HA Boushey… - Journal of Allergy and …, 2002 - Elsevier
Background: A clinical model is needed to compare inhaled corticosteroids (ICSs) with
respect to efficacy. Objective: The purpose of this investigation was to compare the relative …

Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case–control study using Quebec's public health …

M Durand, O Sheehy, JG Baril, J Lelorier… - JAIDS Journal of …, 2011 - journals.lww.com
Background: Morbidity associated with cardiovascular disease is increasing in the HIV-
infected population. We aimed to study the impact of HIV and of antiretrovirals on acute …

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease–2007 update

DE O'donnell, S Aaron, J Bourbeau… - Canadian …, 2007 - Wiley Online Library
Chronic obstructive pulmonary disease (COPD) is a major respiratory illness in Canada that
is both preventable and treatable. Our understanding of the pathophysiology of this complex …

Ocular complications of topical, peri-ocular, and systemic corticosteroids

MC Carnahan, DA Goldstein - Current opinion in ophthalmology, 2000 - journals.lww.com
Topical ophthalmic, oral, and intravenous corticosteroids have long been associated with
ocular side effects. Recent data suggest that inhaled corticosteroids are also associated with …

Locally administered ocular corticosteroids: benefits and risks

CNJ McGhee, S Dean, H Danesh-Meyer - Drug Safety, 2002 - Springer
Corticosteroids, used prudently, are one of the most potent and effective modalities available
in the treatment of ocular inflammation. However, they can produce a plethora of adverse …

Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD

D Price, B Yawn, G Brusselle, A Rossi - Primary Care Respiratory …, 2013 - nature.com
While the pharmacological management of chronic obstructive pulmonary disease (COPD)
has evolved from the drugs used to treat asthma, the treatment models are different and the …

Inhaled corticosteroids in COPD: the clinical evidence

P Ernst, N Saad, S Suissa - European Respiratory Journal, 2015 - Eur Respiratory Soc
In this article, we focus on the scientific evidence from randomised trials supporting
treatment with inhaled corticosteroids (ICS) in chronic obstructive pulmonary disease …

Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis

V Schneider, LE Lévesque, B Zhang… - American Journal of …, 2006 - academic.oup.com
Conventional nonsteroidal antiinflammatory drugs (NSAIDs) are associated with acute renal
failure, but cyclooxygenase-2 inhibitors have not been comparatively evaluated. The authors …

Exacerbation rate, health status and mortality in COPD–a review of potential interventions

TA Seemungal, JR Hurst… - International journal of …, 2009 - Taylor & Francis
COPD is prevalent in Western society and its incidence is rising in the developing world.
Acute exacerbations of COPD, about 50% of which are unreported, lead to deterioration in …